NEWS
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Friday, 5th December at 10:30 am
MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq's technology can enhance the oral delivery of oil-soluble and poorly soluble drugs.
Across two complementary preclinical studies, the results showed a more rapid absorption of an oil soluble compound in Gelteq's gel base compared to an existing FDA approved reference product, with a 300 percent increase in bioavailability across the first hour. High bioavailability in the first hour is critical for rapid onset of action.
Further results demonstrated that the oil soluble compound wasn't just more rapidly absorbed in Gelteq's gel base, but the overall absorption was also improved. Over 24 hours, the absorption was improved by more than 20 percent overall compared to an existing FDA approved reference product. These findings further illustrate that Gelteq's gel matrix can support the delivery of lipophilic compounds whilst moderating the need for high levels of emulsifiers.
The study results also demonstrate that Gelteq's platform enables controlled movement through the digestive system, targeted release, and effective absorption while maintaining full clearance of both the active pharmaceutical ingredients (API) and the gel material itself.
Friday, 5th December at 10:30 am
MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq's technology can enhance the oral delivery of oil-soluble and poorly soluble drugs.
Across two complementary preclinical studies, the results showed a more rapid absorption of an oil soluble compound in Gelteq's gel base compared to an existing FDA approved reference product, with a 300 percent increase in bioavailability across the first hour. High bioavailability in the first hour is critical for rapid onset of action.
Further results demonstrated that the oil soluble compound wasn't just more rapidly absorbed in Gelteq's gel base, but the overall absorption was also improved. Over 24 hours, the absorption was improved by more than 20 percent overall compared to an existing FDA approved reference product. These findings further illustrate that Gelteq's gel matrix can support the delivery of lipophilic compounds whilst moderating the need for high levels of emulsifiers.
The study results also demonstrate that Gelteq's platform enables controlled movement through the digestive system, targeted release, and effective absorption while maintaining full clearance of both the active pharmaceutical ingredients (API) and the gel material itself.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Your actions are your signature—karma is the ink that never fades. Truth walks, lies limp.
21K
Followers
28
Following
345K
Visitors
Follow
Market Insights
Hot Topics Hot Topics
The Week Kicks Off: Davos Forum, PCE Data, Earnings From NFLX、INTC
A jam-packed week: Trump attends Davos, earnings season accelerates with Netflix, Intel reporting, and all eyes turn to Tuesday's Supreme Co
In One Chart
Dec 1, 2025 13:36
December's Must-See Financial Events: FOMC Meeting, Jobs and Inflation Data, Santa Claus Rally, and More
Moomoo Insights
Dec 24, 2025 22:09
U.S. E-commerce vs. Traditional Retailers: Is a Battle Inevitable? A Comparison of Amazon and Walmart
Chxxx CCH : don't mind me asking if holding KALA at the price of .86 safe?
Chxxx CCH Chxxx CCH : just need advise. thank you
DrJaguar8 OP Chxxx CCH : I dont reallt give holding buyjng or selling advice. if you are green, secure profits. It is a Friday
Chxxx CCH : sorry to have bothered you.... tot of just get in to hold till next week. appreciate your reply!
DrJaguar8 OP Chxxx CCH : Friday is tricky because people usuallt close out positions for the week and re-enter next week if warranted